224 related articles for article (PubMed ID: 33580477)
1. Sex Differences in the Risk of Cutaneous Adverse Drug Reactions Induced by Antiseizure Medications: A Systematic Review and Meta-analysis.
Alfares I; Javaid MS; Chen Z; Anderson A; Antonic-Baker A; Kwan P
CNS Drugs; 2021 Feb; 35(2):161-176. PubMed ID: 33580477
[TBL] [Abstract][Full Text] [Related]
2. Association Between HLA-B*1301 and Dapsone-Induced Cutaneous Adverse Drug Reactions: A Systematic Review and Meta-analysis.
Tangamornsuksan W; Lohitnavy M
JAMA Dermatol; 2018 Apr; 154(4):441-446. PubMed ID: 29541744
[TBL] [Abstract][Full Text] [Related]
3. Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population.
Mushiroda T; Takahashi Y; Onuma T; Yamamoto Y; Kamei T; Hoshida T; Takeuchi K; Otsuka K; Okazaki M; Watanabe M; Kanemoto K; Oshima T; Watanabe A; Minami S; Saito K; Tanii H; Shimo Y; Hara M; Saitoh S; Kinoshita T; Kato M; Yamada N; Akamatsu N; Fukuchi T; Ishida S; Yasumoto S; Takahashi A; Ozeki T; Furuta T; Saito Y; Izumida N; Kano Y; Shiohara T; Kubo M;
JAMA Neurol; 2018 Jul; 75(7):842-849. PubMed ID: 29610831
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous reactions induced by oxcarbazepine in Southern Han Chinese: incidence, features, risk factors and relation to HLA-B alleles.
He N; Min FL; Shi YW; Guo J; Liu XR; Li BM; Zhou JH; Ou YM; Liao JX; Liao WP
Seizure; 2012 Oct; 21(8):614-8. PubMed ID: 22818943
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program.
Lange-Asschenfeldt C; Grohmann R; Lange-Asschenfeldt B; Engel RR; Rüther E; Cordes J
J Clin Psychiatry; 2009 Sep; 70(9):1258-65. PubMed ID: 19538904
[TBL] [Abstract][Full Text] [Related]
6. HLA-A∗24:02 associated with lamotrigine-induced cutaneous adverse drug reactions: A systematic review and meta-analysis.
Li W; Wang J; Lin H; Shen G
Medicine (Baltimore); 2020 Dec; 99(52):e23929. PubMed ID: 33350798
[TBL] [Abstract][Full Text] [Related]
7. Incidence rates of severe cutaneous adverse reactions due to antiseizure medication: A nationwide study using health claims data in Korea.
Chung SJ; Ahn KM; Oh JH; Shim JS; Park HW
Epilepsia; 2021 Jan; 62(1):250-257. PubMed ID: 33188522
[TBL] [Abstract][Full Text] [Related]
8. Incidence of cutaneous adverse drug reactions among medical inpatients of Sultanah Aminah Hospital Johor Bahru.
Latha S; Choon SE
Med J Malaysia; 2017 Jun; 72(3):151-156. PubMed ID: 28733562
[TBL] [Abstract][Full Text] [Related]
9. Selective serotonin reuptake inhibitor and serotonin-norepinephrine reuptake inhibitor associated cutaneous adverse drug reactions: A systematic review of case reports and case series.
Masuka JT; Mchunu N; Mkhize Z; Thandar Y; Mosam A
Australas J Dermatol; 2022 Feb; 63(1):e13-e20. PubMed ID: 34958129
[TBL] [Abstract][Full Text] [Related]
10. Clinical profile of cutaneous adverse drug reactions: a retrospective study of 1883 hospitalized patients from 2007 to 2016 in Shanghai, China.
Yang F; Chen Z; Chen SA; Zhu Q; Wang L; Xiong H; Fu H; Luo X
Eur J Dermatol; 2020 Feb; 30(1):24-31. PubMed ID: 32031529
[TBL] [Abstract][Full Text] [Related]
11. Sex Differences in Adverse Effects of Antiseizure Medications in Adults with Epilepsy: A Systematic Review.
Giuliano L; Durante V; Battaglia G; Gasparini S; Zambrelli E; Ermio C; La Neve A; Mostacci B;
CNS Drugs; 2024 Jun; 38(6):409-423. PubMed ID: 38691320
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism of cytochrome P450 2C9 in diphenylhydantoin-induced cutaneous adverse drug reactions.
Lee AY; Kim MJ; Chey WY; Choi J; Kim BG
Eur J Clin Pharmacol; 2004 May; 60(3):155-9. PubMed ID: 15024534
[TBL] [Abstract][Full Text] [Related]
13. Trends in culprit drugs and clinical entities in cutaneous adverse drug reactions: a retrospective study.
Wang F; Zhao YK; Li M; Zhu Z; Zhang X
Cutan Ocul Toxicol; 2017 Dec; 36(4):370-376. PubMed ID: 28423957
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced liver injury associated with antiseizure medications from the FDA Adverse Event Reporting System (FAERS).
Kamitaki BK; Minacapelli CD; Zhang P; Wachuku C; Gupta K; Catalano C; Rustgi V
Epilepsy Behav; 2021 Apr; 117():107832. PubMed ID: 33626490
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous cutaneous adverse drug reaction reports-An analysis of a 10-year dataset in Singapore.
Wong SX; Tham MY; Goh CL; Cheong HH; Chan SY
Pharmacol Res Perspect; 2019 Apr; 7(2):e00469. PubMed ID: 30911397
[TBL] [Abstract][Full Text] [Related]
16. CD4 count and risk of anti-tuberculosis drug-associated cutaneous reactions in HIV-infected Thai patients.
Boonyagars L; Hirunwiwatkul P; Hurst CP
Int J Tuberc Lung Dis; 2017 Mar; 21(3):338-344. PubMed ID: 28225346
[TBL] [Abstract][Full Text] [Related]
17. A Study of Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Andhra Pradesh, India.
Ashifha S; Vijayashree J; Vudayana K; Chintada D; P P; G P; Unnikrishnan P
Cureus; 2023 Apr; 15(4):e37596. PubMed ID: 37197134
[TBL] [Abstract][Full Text] [Related]
18. An Epidemiological and Clinical Analysis of Cutaneous Adverse Drug Reactions Seen in a Tertiary Care Outpatient Clinic in Cairo, Egypt.
El-Nabarawy EA; Elmasry MF; El Lawindi MI; Tarek YA
Acta Dermatovenerol Croat; 2018 Oct; 26(3):233-242. PubMed ID: 30390725
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous adverse drug reactions with fixed-dose combinations: Special reference to self-medication and preventability.
Tripathy R; Pattnaik KP; Dehury S; Patro S; Mohanty P; Sahoo SS; Mohanty S
Indian J Pharmacol; 2018; 50(4):192-196. PubMed ID: 30505055
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous adverse drug reactions to psychotropic drugs and their risk factors - a case-control study.
Greil W; Zhang X; Stassen H; Grohmann R; Bridler R; Hasler G; Toto S; Bleich S; Kasper S
Eur Neuropsychopharmacol; 2019 Jan; 29(1):111-121. PubMed ID: 30424913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
